je.st
news
Analysts: New inversion rules will kill Pfizer-Allergan deal
2016-04-05 22:25:51| Biotech - Topix.net
In this Monday, Nov. 23, 2015, file photo, the Allergan logo appears above a trading post on the floor of the New York Stock Exchange. Pfizer Inc. and Allergan Plc are scrambling to determine whether to proceed with their plan to merge.
Tags: rules
deal
kill
analysts
Category:Biotechnology and Pharmaceuticals